Covered recipient · General Payments record
SANJOY MUKERJEE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$346.91
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $171.35 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $42.23 | 3 |
| Exact Sciences Corporation | $37.98 | 2 |
| Teva Pharmaceuticals USA, Inc. | $37.04 | 2 |
| Lilly USA, LLC | $27.89 | 2 |
| Gilead Sciences, Inc. | $26.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.85 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117635715 | CMS |
| Amgen Inc. | $14.26 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115950297 | CMS |
| Amgen Inc. | $13.12 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117635717 | CMS |
| Exact Sciences Corporation | $18.26 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114799822 | CMS |
| Exact Sciences Corporation | $19.72 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114799827 | CMS |
| Gilead Sciences, Inc. | $26.21 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133743187 | CMS |
| Lilly USA, LLC | $13.94 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135405692 | CMS |
| Lilly USA, LLC | $13.95 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135375262 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.38 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151546040 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.66 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151546074 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.